Neutralization of leukotriene C4 and D4 activity by monoclonal and single-chain antibodies

Biochimica et Biophysica Acta - General Subjects

Volumn 1840, Issue 6, 2014, Pages 1625-1633

  Kawakami, Yuki ^a   Hirano, Shiori ^a   Kinoshita, Mai ^a   Otsuki, Akemi ^a   Suzuki Yamamoto, Toshiko ^a   Suzuki, Makiko ^a   Kimoto, Masumi ^a   Sasabe, Sae ^a   Fukushima, Mitsuo ^a   Kishimoto, Koji ^b   Izumi, Takashi ^b   Oga, Toru ^c   Narumiya, Shuh ^c   Sugahara, Mitsuaki ^d   Miyano, Masashi ^d,e   Yamamoto, Shozo ^f   Takahashi, Yoshitaka ^a  

^a OKAYAMA PREFECTURAL UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d RIKEN SPring 8 Center   (Japan)

^e AOYAMA GAKUIN UNIVERSITY   (Japan)

^f KYOTO WOMEN'S UNIVERSITY   (Japan)

Author keywords

Arachidonic acid; Cysteinyl leukotriene; Monoclonal antibody; Single chain variable fragment

Indexed keywords

INTERLEUKIN 8; LEUKOTRIENE C4; LEUKOTRIENE C4 MONOCLONAL ANTIBODY; LEUKOTRIENE D4; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG; ARACHIDONIC ACID; CYSTEINYL LEUKOTRIENE RECEPTOR 2; CYTOKINE; LEUKOTRIENE RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONOCLONAL ANTIBODY; PEPTIDOLEUKOTRIENE;

ANIMAL CELL; ARTICLE; FEMALE; GENE OVEREXPRESSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ASTHMA; BIOSYNTHESIS; C57BL MOUSE; CHO CELL LINE; CRICETULUS; CYSLT(1) RECEPTOR; CYSLT(2) RECEPTOR; DRUG EFFECT; HAMSTER; HUMAN; IMMUNOLOGY; MALE; MOUSE; PHYSIOLOGY; SINGLE-CHAIN VARIABLE FRAGMENT; THROMBOCYTE AGGREGATION;

ARACHIDONIC ACID; CYSLT(1) RECEPTOR; CYSLT(2) RECEPTOR; CYSTEINYL LEUKOTRIENE; MONOCLONAL ANTIBODY; SINGLE-CHAIN VARIABLE FRAGMENT;

ANIMALS; ANTIBODIES, MONOCLONAL; ASTHMA; CHO CELLS; CRICETINAE; CRICETULUS; CYTOKINES; HUMANS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENE C4; LEUKOTRIENE D4; MALE; MICE; MICE, INBRED C57BL; PLATELET AGGREGATION; RECEPTORS, LEUKOTRIENE; SINGLE-CHAIN ANTIBODIES;

EID: 84897882911     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2013.12.016     Document Type: Article

References (42)

1. B. Samuelsson, Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation, Science 220 (1983) 568-575. (Pubitemid 13130140)
2. S. Yamamoto, Mammalian lipoxygenases: molecular structures and functions, Biochim. Biophys. Acta 1128 (1992) 117-131.
3. M. Bäck, S.-E. Dahlén, J.M. Drazen, J.F. Evans, C.N. Serhan, T. Shimizu, T. Yokomizo, G.E. Rovati, International union of basic and clinical pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functions, Pharmacol. Rev. 63 (2011) 539-584.
4. K.R. Lynch, G.P. O'Neill, Q. Liu, D.S. Im, N. Sawyer, K.M. Metters, N. Coulombe, M. Abramovitz, D.J. Figueroa, Z. Zeng, B.M. Connolly, C. Bai, C.P. Austin, A. Chateauneuf, R. Stocco, G.M. Greig, S. Kargman, S.B. Hooks, E. Hosfield, D.L. Williams Jr., A.W. Ford-Hutchinson, C.T. Caskey, J.F. Evans, Characterization of the human cysteinyl leukotriene CysLT1 receptor, Nature 399 (1999) 789-793. (Pubitemid 29293175)
5. 2: differential pharmacological properties and tissue distribution, J. Biol. Chem. 277 (2002) 18763-18768.
6. J. Takasaki, M. Kamohara, M. Matsumoto, T. Saito, T. Sugimoto, T. Ohishi, H. Ishii, T. Ota, T. Nishikawa, Y. Kawai, Y. Masuho, T. Isogai, Y. Suzuki, S. Sugano, K. Furuichi, The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT2 receptor, Biochem. Biophys. Res. Commun. 274 (2000) 316-322. (Pubitemid 30614317)
7. N.C. Barnes, J.C. Pujet, Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicentre clinical study in asthma, Thorax 52 (1997) 523-527. (Pubitemid 27298503)
8. S. Suissa, R. Dennis, P. Ernst, O. Sheehy, S. Wood-Dauphinee, Effectiveness of the leukotriene receptor antagonist za firlukast for mild-to-moderate asthma. A randomized, double-blind, placebo-controlled trial, Ann. Intern. Med. 126 (1997) 177-183. (Pubitemid 27061570)
9. L.C. Altman, Z. Munk, J. Seltzer, N. Noonan, S. Shingo, J. Zhang, T.F. Reiss, A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene-receptor antagonist. Montelukast asthma study group, J. Allergy Clin. Immunol. 102 (1998) 50-56. (Pubitemid 28345784)
10. T.C. Beller, A. Maekawa, D.S. Friend, K.F. Austen, Y. Kanaoka, Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice, J. Biol. Chem. 279 (2004) 46129-46134. (Pubitemid 39491607)
11. M.K. Oyoshi, R. He, Y. Kanaoka, A. ElKhal, S. Kawamoto, C.N. Lewis, K.F. Austen, R.S. Geha, Eosinophil-derived leukotriene C4 signals via type 2 cysteinyl leukotriene receptor to promote skin fibrosis in a mouse model of atopic dermatitis, Proc. Natl. Acad. Sci. U. S. A. 109 (2012) 4992-4997.
12. 2) receptor, Br. J. Pharmacol. 160 (2010) 399-409.
13. N.C. Ni, D. Yan, L.L. Ballantyne, A. Barajas-Espinosa, T. St. Amand, D.A. Pratt, C.D. Funk, A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice, J. Pharmacol. Exp. Ther. 339 (2011) 768-778.
14. 4 prior to radioimmunoassay: application to human synovial fluid, Ann. Clin. Biochem. 30 (1993) 60-68.
15. 4, Biochem. Biophys. Res. Commun. 392 (2010) 421-425.
16. H. Niwa, K. Yamamura, J. Miyazaki, Ef ficient selection for high-expression transfectants with a novel eukaryotic vector, Gene 108 (1991) 193-199.
17. J. Winer, C.K. Jung, I. Shackel, P.M. Williams, Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro, Anal. Biochem. 270 (1999) 41-49. (Pubitemid 29230718)
18. H. Tanaka, H. Nagai, Y. Maeda, Effect of anti-IL-4 and anti-IL-5 antibodies on allergic airway hyperresponsiveness in mice, Life Sci. 62 (1998) L169-PL174.
19. 2 as a mediator of allergic asthma, Science 287 (2000) 2013-2017.
20. 4 receptor antagonists, J. Pharmacol. Exp. Ther. 269 (1994) 891-896.
21. 4 receptor in the human THP-1 cell line, Biochim. Biophys. Acta 1177 (1993) 283-290.
22. 2+-induced IL-8 production in human mast cells, Cytokine 32 (2005) 226-233.
23. 2, J. Immunol. 155 (1995) 4437-4444.
24. α- Raf-1-dependent pathway in human monocytic leukemia THP-1 cells, J. Biol. Chem. 273 (1998) 4878-4882.
25. T. Ichiyama, M. Hasegawa, Y. Ueno, H. Makata, T. Matsubara, S. Furukawa, Cysteinyl leukotrienes induce monocyte chemoattractant protein 1 in human monocytes/macrophages, Clin. Exp. Allergy 35 (2005) 1214-1219.
26. 1 receptor engagement induces activator protein-1- and NF-κB-dependent IL-8 expression, Am. J. Respir. Cell Mol. Biol. 35 (2006) 697-704.
27. K. Hashimoto, T. Ichiyama, M. Hasegawa, S. Hasegawa, T. Matsubara, S. Furukawa, Cysteinyl leukotrienes induce monocyte chemoattractant protein-1 in human monocyte/macrophages via mitogen-activated protein kinase and nuclear factor-κB pathways, Int. Arch. Allergy Immunol. 149 (2009) 275-282.
28. L.F. Brass, D.R. Manning, K. Cichowski, C.S. Abrams, Signaling through G proteins in platelets: to the integrins and beyond, Thromb. Haemost. 78 (1997) 581-589. (Pubitemid 27289308)
29. S.J. Shattil, H. Kashiwagi, N. Pampori, Integrin signaling: the platelet paradigm, Blood 91 (1998) 2645-2657. (Pubitemid 28227512)
30. B.N. Kahner, H. Shankar, S. Murugappan, G.L. Prasad, S.P. Kunapuli, Nucleotide receptor signaling in platelets, J. Thromb. Haemost. 4 (2006) 2317-2326. (Pubitemid 44575423)
31. J. Grossman, I. Faiferman, J.W. Dubb, D.J. Tompson, W. Busse, E. Bronsky, A. Montanaro, L. Southern, D. Tinkelman, Results of the first U.S. double-blind, placebo-controlled, multicenter clinical study in asthma with pranlukast, a novel leukotriene receptor antagonist, J. Asthma 34 (1997) 321-328. (Pubitemid 27365643)
32. W.R. Henderson Jr., D.B. Lewis, R.K. Albert, Y. Zhang, W.J. Lamm, G.K. Chiang, F. Jones, P. Eriksen, Y.T. Tien, M. Jonas, E.Y. Chi, The importance of leukotrienes in airway inflammation in a mouse model of asthma, J. Exp. Med. 184 (1996) 1483-1494. (Pubitemid 26354703)
33. A. Murai, M. Abe, Y. Hayashi, N. Sakata, T. Katsuragi, K. Tanaka, Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone, J. Pharmacol. Exp. Ther. 312 (2005) 432-440. (Pubitemid 40189539)
34. W.S. Wong, H. Zhu, W. Liao, Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model, Eur. J. Pharmacol. 575 (2007) 134-141. (Pubitemid 47576058)
35. C. Bandeira-Melo, P.F. Weller, Eosinophils and cysteinyl leukotrienes, Prostaglandins Leukot. Essent. Fat. Acids 69 (2003) 135-143. (Pubitemid 36976169)
36. T.C. Beller, D.S. Friend, A. Maekawa, B.K. Lam, K.F. Austen, Y. Kanaoka, Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis, Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 3047-3052. (Pubitemid 38327732)
37. N.A. Barrett, J.M. Fernandez, A. Maekawa, W. Xing, L. Li, M.W. Parsons, K. F. Austen, Y. Kanaoka, Cysteinyl leukotriene 2 receptor on dendritic cells negatively regulates ligand-dependent allergic pulmonary inflammation, J. Immunol. 189 (2012) 4556-4565.
38. 1 receptors and down-modulate cysteinyl leukotriene-dependent mitogenic responses of mast cells, Blood 110 (2007) 3263-3270.
39. W.Y. Hwang, J. Foote, Immunogenicity of engineered antibodies, Methods 36 (2005) 3-10. (Pubitemid 40558811)
40. K. Bendtzen, Anti-TNF-alpha biotherapies: perspectives for evidence-based personalized medicine, Immunotherapy 4 (2012) 1167-1179.
41. T. Tanaka, T. Kishimoto, Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases, Int. J. Biol. Sci. 8 (2012) 1227-1236.
42. G. Pelaia, A. Vatrella, R. Maselli, The potential of biologics for the treatment of asthma, Nat. Rev. Drug Discov. 11 (2012) 958-972.